Boston Megan insider trades
Boston Megan has filed 5 Form 4s with the SEC that we hold, all for Benitec Biopharma Inc. (BNTC), as Chief Financial Officer, Director. Across all of them we count 1 purchase worth $0 and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The first filing on our record is dated 2023-06-15 and the latest 2025-11-20.
Benitec Biopharma Inc. (BNTC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-11 | P, purchase reported on Form 4 | 25,907 | - | 2023-08-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1808923) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms